Related Experiment Videos
Improving surgical resection rate in lung cancer
C Laroche1, F Wells, R Coulden
1Thoracic Oncology Unit, Papworth NHS Trust, Papworth Hospital, Papworth Everard, Cambridgeshire, UK.
Thorax
|August 26, 1998
Summary
A rapid investigation service significantly increased surgical resection rates for non-small cell lung cancer (NSCLC) in the UK. This highlights potential barriers to timely curative surgery in current healthcare systems.
Area of Science:
- Oncology
- Thoracic Surgery
- Public Health
Background:
- Surgical resection is the primary treatment for early-stage non-small cell lung cancer (NSCLC).
- UK surgical resection rates for NSCLC are significantly lower than in Europe and the USA.
- The reasons for this disparity remain unclear despite improved investigation services.
Discussion:
- A new rapid investigation service was implemented to streamline diagnosis and treatment pathways for suspected lung cancer.
- Multidisciplinary team reviews, including oncologists and thoracic surgeons, were integral to patient management.
- The study aimed to assess the impact of this service on surgical resection rates and treatment times.
Key Insights:
- The rapid investigation service achieved a 25% surgical resection rate for non-small cell lung cancer (NSCLC), with 80% of resections being for Stage I or II disease.
- Median time from presentation to surgery was 5 weeks.
- High rates of histological confirmation and routine CT scanning contributed to successful surgical outcomes.
Outlook:
- The findings suggest that many operable lung cancer patients may be missing opportunities for curative surgery within the existing system.
- Implementing similar rapid access services could improve surgical resection rates for NSCLC.
- Further research is needed to identify and address systemic barriers to timely surgical intervention.